	US 11,988,660 B2
	Rapid screening for infectious diseases
Richard Postrel, Miami Beach, FL (US)
Appl. No. 17/609,165
Filed by Richard Postrel, Miami Beach, FL (US)
PCT Filed Aug. 5, 2021, PCT No. PCT/US2021/044852 § 371(c)(1), (2) Date Nov. 5, 2021, PCT Pub. No. WO2022/032039, PCT Pub. Date Feb. 10, 2022.
Claims priority of provisional application 63/190,573, filed on May 19, 2021.
Claims priority of provisional application 63/061,159, filed on Aug. 4, 2020.
Prior Publication US 2023/0251243 A1, Aug. 10, 2023
Int. Cl. G01N 33/497 (2006.01); B01L 5/02 (2006.01); B01L 7/00 (2006.01); G01N 33/543 (2006.01)

CPC G01N 33/497 (2013.01) [B01L 5/02 (2013.01); B01L 7/00 (2013.01); G01N 33/54373 (2013.01); B01L 2300/044 (2013.01)]

31 Claims

1. An analytical device comprising a detector unit capable of interfacing with an analytical unit, said detector unit comprising a module designed to collect a vapor phase;

sample for delivery to a plurality of detection surfaces capable of interacting with said vapor phase;

said detection surface comprising a nano-sensor element (NSE) layer between an input and an output;

said input in contact with a base power source;

said output in communication with at least one data collector;

said NSE layer associated with a selection component with selection specificity for one or more compounds of interest;

said selection component when in contact with or in close proximity to a target compound present in said vapor phase selectively altering signal to said output; and

a component for collecting said signal from said output.